TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Concord Medical Services ( (CCM) ) just unveiled an announcement.
Concord Healthcare, a subsidiary of Concord Medical Services Holdings Limited, announced its interim results for the first half of 2025 on August 28, 2025. The announcement follows the listing of Concord Healthcare’s H shares on the Hong Kong Stock Exchange in January 2024, indicating a strategic move to enhance its market presence and financial transparency.
The most recent analyst rating on (CCM) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Concord Medical Services stock, see the CCM Stock Forecast page.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Neutral.
Concord Medical Services is facing significant financial challenges, with persistent losses and high leverage being the most critical factors. The technical analysis suggests bearish momentum, and the negative P/E ratio highlights valuation concerns. The absence of earnings call data and corporate events does not alter the overall negative outlook.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited operates in the healthcare industry, focusing on providing medical services. It is involved in the management and operation of radiotherapy and diagnostic imaging centers and is listed on the New York Stock Exchange under the ticker CCM.
Average Trading Volume: 10,389
Technical Sentiment Signal: Strong Sell
Current Market Cap: $24.51M
For an in-depth examination of CCM stock, go to TipRanks’ Overview page.